John Paulson Biography and Net Worth

Director of Bausch Health Cos

Mr. Paulson is the President and Portfolio Manager of Paulson & Co. Inc., an SEC-registered investment management company specializing in global mergers, event arbitrage and credit strategies, which he founded in 1994. Prior to forming Paulson & Co. Inc., Mr. Paulson was a Partner of Gruss Partners and a Managing Director in mergers and acquisitions at Bear Stearns. Mr. Paulson received his undergraduate degree from New York University in 1978 and his Master of Business Administration from Harvard Business School in 1980. Mr. Paulson has been a Director of BrightSphere Investment Group Inc., a publicly traded asset management holding company, since November 2018, and has served as Chairman since April 2020. He also currently serves as a member of the Advisory Board of Harvard Business School. He previously served as a Director of American International Group Inc. from May 2016 to June 2017. In June 2022, Mr. Paulson was appointed Chairman of the Board for Bausch Health.

What is John Paulson's net worth?: The estimated net worth of John Paulson is at least $281.12 million as of August 14th, 2025. Paulson owns 37,964,167 shares of Bausch Health Cos stock worth more than $281,124,657 as of December 5th. This net worth estimate does not reflect any other investments that Paulson may own. Learn More about John Paulson's net worth.
How do I contact John Paulson?: The corporate mailing address for Paulson and other Bausch Health Cos executives is 2150 ST. ELZEAR BLVD. WEST, LAVAL A8, H7L 4A8. Bausch Health Cos can also be reached via phone at (514) 744-6792 and via email at [email protected]. Learn More on John Paulson's contact information.
Has John Paulson been buying or selling shares of Bausch Health Cos?: John Paulson has not been actively trading shares of Bausch Health Cos during the last ninety days. Most recently, on Thursday, August 14th, John Paulson bought 34,721,118 shares of Bausch Health Cos stock. The stock was acquired at an average cost of $9.00 per share, with a total value of $312,490,062.00. Following the completion of the transaction, the director now directly owns 70,755,869 shares of the company's stock, valued at $636,802,821. Learn More on John Paulson's trading history.
Who are Bausch Health Cos' active insiders?: Bausch Health Cos' insider roster includes Christina Ackermann (EVP), Seana Carson (EVP), Richard DeSchutter (Director), Sam Eldessouky (CFO), Joseph Gordon (Insider), William Humphries (Insider), Steven Miller (Director), John Paulson (Director), Robert Spurr (Insider), and Amy Wechsler (Director). Learn More on Bausch Health Cos' active insiders.
Are insiders buying or selling shares of Bausch Health Cos?: In the last year, Bausch Health Cos insiders bought shares 8 times. They purchased a total of 44,316,834 shares worth more than $369,628,560.14. The most recent insider tranaction occured on August, 14th when Director John Paulson bought 34,721,118 shares worth more than $312,490,062.00. Insiders at Bausch Health Cos own 20.0% of the company. Learn More about insider trades at Bausch Health Cos.
Information on this page was last updated on 8/14/2025.

John Paulson Insider Trading History at Bausch Health Cos

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/14/2025	Buy	34,721,118	$9.00	$312,490,062.00	70,755,869
8/13/2025	Buy	86,409	$7.06	$610,047.54	36,034,751
8/12/2025	Buy	1,156,640	$6.88	$7,957,683.20	35,948,342
8/11/2025	Buy	2,000,000	$6.35	$12,700,000.00	34,791,702
6/13/2025	Buy	3,564,059	$5.94	$21,170,510.46	32,791,702
6/12/2025	Buy	1,005,376	$5.47	$5,499,406.72	29,227,643
6/11/2025	Buy	1,029,098	$5.24	$5,392,473.52	28,222,267
6/10/2025	Buy	754,134	$5.05	$3,808,376.70	27,193,169
5/14/2020	Buy	1,628,920	$15.87	$25,850,960.40
5/12/2020	Buy	2,041,036	$17.35	$35,411,974.60
3/6/2018	Buy	7,066,629	$15.40	$108,826,086.60
11/16/2017	Buy	344,216	$14.40	$4,956,710.40	94,559

John Paulson Buying and Selling Activity at Bausch Health Cos

Bausch Health Cos Company Overview

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Today's Range

Now: $7.41

$7.07

$7.55

50 Day Range

MA: $6.43

$5.90

$7.41

2 Week Range

Now: $7.41

$4.25

$8.69

Volume

4,729,236 shs

Average Volume

2,805,087 shs

Market Capitalization

$2.75 billion

P/E Ratio

7.63

Dividend Yield

N/A

Beta

0.41